atag 4531

Degrader of MTH1 fusion proteins for use within the aTAG system. Comprises a ligand selective for MTH1, a linker and the cereblon-binding ligand Thalidomide . Induces highly potent and selective degradation of fusion proteins after a 4 h incubation (DC50 = 0.34 nM; Dmax = 93.14%). Cell-permeable. Suitable for in vitro and in vivo applications. Mouse DMPK properties are provided in the supplementary file (see below). (MTH1 can be expressed as a fusion with a target protein of interest using genome engineering techniques via CRISPR-mediated locus-specific knock-in - see protocol for more information.) 0

Thalidomide-O-Triazole-C4-amino 为一种E3 泛素酶配体-连接子偶联物（E3 Ligase Ligand-linker conjugate），主要应用于aTAG 4531的合成。

MTH1 degrader-1 是MTH1 aTAG抑制剂，也是PROTAC靶蛋白配体 (Ligand for Target Protein for PROTAC)，可用于合成PROTAC aTAG 4531。